Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell
Serge‐Daniel Le Bon(Université Libre de Bruxelles), Mihaéla Horoi(Université Libre de Bruxelles), Nathalie Pisarski(Université Libre de Bruxelles), Léa Prunier(Université Libre de Bruxelles), Jérôme R. Lechien(University of Mons), Déborah Konopnicki(Université Libre de Bruxelles)
Cited by 120
Related Papers
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
|European Archives of Oto-Rhino-Laryngology|2020|2.8k
Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
|Journal of Internal Medicine|2020|847
Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review
|Otolaryngology|2019|372
Prevalence and 6‐month recovery of olfactory dysfunction: a multicentre study of 1363 COVID‐19 patients
|Journal of Internal Medicine|2021|244
Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19
|Annals of Internal Medicine|2020|202